Veterinary Medicines

PANA VEYXAL, tepalas

Authorised
  • ALPHATOCOPHEROL ACETATE
  • Retinol palmitate
  • Papain
  • Trypsin
  • Chymotrypsin
  • PANCREATIN
Download as PDF

Product identification

Medicine name:
PANA VEYXAL, tepalas
Active substance:
  • ALPHATOCOPHEROL ACETATE
  • Retinol palmitate
  • Papain
  • Trypsin
  • Chymotrypsin
  • PANCREATIN
Target species:
  • Horse
  • Cattle
  • Pig
  • Sheep
  • Goat
  • Dog
  • Cat
Route of administration:
  • External use

Product details

Active substance and strength:
  • ALPHATOCOPHEROL ACETATE
    25.00
    milligram(s)
    /
    10.00
    gram(s)
  • Retinol palmitate
    42500.00
    international unit(s)
    /
    10.00
    gram(s)
  • Papain
    18.50
    milligram(s)
    /
    10.00
    gram(s)
  • Trypsin
    8.60
    milligram(s)
    /
    10.00
    gram(s)
  • Chymotrypsin
    1.70
    milligram(s)
    /
    10.00
    gram(s)
  • PANCREATIN
    4.50
    milligram(s)
    /
    10.00
    gram(s)
Pharmaceutical form:
  • Ointment
Withdrawal period by route of administration:
  • External use
    • Horse
    • Cattle
    • Pig
    • Sheep
    • Goat
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/02/1371/001-002
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 14/10/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."